Timothy Wilkin, MD
Enriched profileProfessor of Medicine, Head of Infectious Diseases and Global Public Health · University of California, San Diego
Timothy Wilkin is Professor of Medicine, Head of Infectious Diseases and Global Public Health at University of California, San Diego. OpenAlex indexes 159 publications with 5,923 citations (h-index 33); ClinicalTrials.gov lists 12 registered studies with this person as an investigator.
Data verified 15 Oct 2026
Overview
Updated 16 Oct 2026
Timothy Wilkin, MD, is Professor of Medicine, Head of Infectious Diseases and Global Public Health at University of California, San Diego. The public record shows 159 publications with 5,923 citations (h-index 33), centered on HIV/AIDS Research and Interventions, HIV/AIDS drug development and treatment, HIV Research and Treatment. It also documents an investigator role on 12 registered clinical trials, industry payments reported by 4 companies, 2 NIH-funded awards (2024–2026).
- Most recent indexed publication: 2026 · Clinical infectious diseases
- Top research focus: HIV/AIDS Research and Interventions
- 12 registered trials on ClinicalTrials.gov
- Open Payments reporting from 4 companies
Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 4 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 79.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 16 Oct 2026
Listed as an investigator on 12 registered studies on ClinicalTrials.gov. The most recent:
- Testing the Feasibility of Different HPV Screening and Care Strategies for Women Living With HIV
Sponsor: University of California, San Diego
- CASCADE: Testing for Safety and Immune Effects of PDS0101, an Anti-HPV Therapy, Among People Living With HIV
Sponsor: University of California, San Diego
Industry payments
Updated 16 Oct 2026
4 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year202534 payments$32,672openpaymentsdata.cms.gov ↗
- Merck Sharp & Dohme LLCProgram year202415 payments$10,079openpaymentsdata.cms.gov ↗
- ViiV Healthcare CompanyProgram year20246 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
100%Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor100%Juluca100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 16 Oct 2026
2 NIH research awards on record, funded 2024–2026 per NIH RePORTER. The latest:
- UCSD Collaborative Clinical Trials Unit
University of California, San Diego
FY2026$3,294,545UM1AI069432 - UCSD Collaborative Clinical Trials Unit
University of California, San Diego
FY2026$1,050,352UM1AI069432 - Partnership for advancing cervical cancer prevention in women living with HIV (CASCADE - Research Hub)
University of California, San Diego
FY2026$87,368UG1CA275414
Publications
Updated 16 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Clinical Consequences of Delaying Implementation of Long-Acting Antiretroviral Therapy for People With HIV and Persistent Viremia in the United States.
Clinical infectious diseases
Article2026 - Enhanced Clearance of HIV-1 Broadly Neutralizing Antibody VRC07-523-LS During Viremia: Influences on Trial Design and Analysis.
Clinical and translational science
Article2026 - Review of human papillomavirus (HPV) burden and HPV vaccination for gay, bisexual, and other men who have sex with men and transgender women in the United States.
Human vaccines & immunotherapeutics
Review2022 - The Association between Smoking and Anal Human Papillomavirus in the HPV Infection in Men Study.
Cancer epidemiology, biomarkers & prevention
Article2022
Most-cited works
by citation count (OpenAlex)Network
Updated 16 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 16 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/timothy-wilkin-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
doctors.nyp.org/timothy-wilkin-md/acn-east-css-baker
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doctors.nyp.org ↗ - Other
profiles.ucsd.edu/timothy.wilkin
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.ucsd.edu ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 16 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
Ohio State University College of Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →anchorstudy.org ↗ - MPH
Columbia University Mailman School of Public Health
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →anchorstudy.org ↗ - Undergraduate degree in Mathematics
University of Texas at Austin
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →anchorstudy.org ↗
Editorial & leadership roles
journal and society appointments- Leader
ACTG STOMP Monkeypox Treatment Study
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →actgnetwork.org ↗
Secondary affiliations
appointments beyond the home institution- Weill Cornell Medicine
Assistant Dean for Clinical Research Compliance
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →anchorstudy.org ↗
Media & interviews
press, podcasts and appearances- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →actgnetwork.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Ravindra Mehta, MD
University of California, San Diego
Barry Greenberg, MD
University of California, San Diego
Anthony Demaria, MD
University of California, San Diego
Arthur Kavanaugh, MD
University of California, San Diego
Baha Sibai, MD
McGovern Medical School at UTHealth Houston
Robert Coleman, MD
Vaniam Group
Kathleen Moore, MD
University of Nebraska Medical Center
Bradley Monk, MD
Florida Cancer Specialists & Research Institute